Sagent Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope

Sagent Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$212.9M

485 transactions

Summary

Sagent Pharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $443KSales: $122.8M35 insiders

Date	Insider	Type	Value
2016-08-29	Harmon J Frank(EVP, Global Operations)	D	$194K
2016-08-29	Yanai Shlomo	D	$186K
2016-08-29	FEKETE MICHAEL	D	$186K
2016-08-29	Harmon J Frank(EVP, Global Operations)	D	$157K
2016-08-29	WARD MICHAEL V.(Chief Legal Off. and Secretary)	D	$119K
2016-08-29	Greve Jeffrey W.(Vice President, Controller)	D	$108K
2016-08-29	Greve Jeffrey W.(Vice President, Controller)	D	$75K
2016-08-29	WARD MICHAEL V.(Chief Legal Off. and Secretary)	D	$75K
2016-08-29	FEKETE MICHAEL	D	$50K
2016-08-29	Yanai Shlomo	D	$48K
2016-08-29	Greve Jeffrey W.(Vice President, Controller)	D	$46K
2016-08-29	FEKETE MICHAEL	U	$44K
2016-08-29	FEKETE MICHAEL	D	$40K
2016-08-29	FEKETE MICHAEL	D	$30K
2016-08-29	WARD MICHAEL V.(Chief Legal Off. and Secretary)	U	$22K
2016-08-29	Yanai Shlomo	D	$16K
2016-08-29	FEKETE MICHAEL	D	$15K
2016-08-29	Greve Jeffrey W.(Vice President, Controller)	D	$14K
2016-08-29	WARD MICHAEL V.(Chief Legal Off. and Secretary)	U	$13K
2016-08-29	FEKETE MICHAEL	D	$13K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR